FDA Social Media Guidance: More Insights and Commentary from Around the Web

Wednesday, January 11, 2012

FDA Social Media Guidance: More Insights and Commentary from Around the Web

One of our go-to healthcare social media observers, P. F. Anderson, has posted a thorough summary of the FDA's new guidance and a roundup of insights and commentary from around the web. Read "FDASM: Initial Draft Guidelines Focus on Social Media Requests for Off-Label Uses" on the Emerging Technologies Librarian blog. See our previous post on the subject. And enjoy the following slide presentation from Palio, a healthcare advertising agency based in Saratoga Springs, New York.

No comments:

Post a Comment

Commenting

Everyone can read and use comments posted to this blog.

Users must have a login recognized by Blogger to make comments.

Users may delete their own comments.

Comments posted on this blog should be designed to support, not replace, the relationship that exists between a patient and their existing physician. Posts and comments on this blog should not be regarded as having been made by medical professionals unless the author is specifically identified as such.

We value civil discourse. Those posting comments must behave with respect and honesty at all times.

Users may only post information which they believe to be true and correct to the best of their knowledge. We encourage users to provide resources (citations or links) on health or medical claims when possible and relevant.

Commercial posts, advertising, and posts done for the purpose of search engine ranking are prohibited.

Comments are moderated occasionally and posteriorly by the HyperbaricLink professional staff. The moderators reserve the right to erase, without notification, any comment they find inappropriate.